Hence, numerous preclinical studies indicate the ability of natural as well as synthetic PPARγ ligands to modulate the tumor cell signaling mechanisms and/or the cross-talk with various extracellular factors and intracellular pathways controlling the growth, survival, and invasive/metastatic behavior of breast cancer cells. This evidence concerns the gene PPARG and breast cancer.